TP53 and neoplasm: There were no statistical differences between the two groups in gender composition, maximum tumor diameter, recurrence rate, TERT mutation, NRAS/HRAS mutation, TSHR mutation, TP53 mutation, PIK3 CA mutation, and NTRK1 mutation (P > 0.05).